Şükrü Palanduz

1.8k total citations
90 papers, 1.0k citations indexed

About

Şükrü Palanduz is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Şükrü Palanduz has authored 90 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 20 papers in Genetics and 14 papers in Hematology. Recurrent topics in Şükrü Palanduz's work include Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (7 papers). Şükrü Palanduz is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (7 papers). Şükrü Palanduz collaborates with scholars based in Türkiye, United States and Germany. Şükrü Palanduz's co-authors include Kıvanç Çefle, Şükrü Öztürk, Evin Ademoğlu, Ayşe Palandüz, Nermin Güler, Cahide Gökkuşu, Stefan Mundlos, Seval Türkmen, Suna Büyüköztürk and Melih Aktan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Chemistry.

In The Last Decade

Şükrü Palanduz

81 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şükrü Palanduz Türkiye 18 400 224 151 101 87 90 1.0k
Luisa Doneda Italy 21 343 0.9× 225 1.0× 264 1.7× 91 0.9× 240 2.8× 84 1.2k
Jingfang Liu China 20 494 1.2× 87 0.4× 148 1.0× 163 1.6× 109 1.3× 104 1.3k
Mercedes García-Bermúdez Spain 20 607 1.5× 174 0.8× 137 0.9× 84 0.8× 66 0.8× 52 1.5k
Noriaki Iino Japan 19 524 1.3× 187 0.8× 70 0.5× 41 0.4× 191 2.2× 66 1.4k
Jau-Yi Li United States 8 613 1.5× 112 0.5× 96 0.6× 63 0.6× 77 0.9× 8 1.3k
Naoko Yokota Japan 20 634 1.6× 204 0.9× 138 0.9× 164 1.6× 293 3.4× 43 1.6k
Pratibha Nallari India 17 357 0.9× 110 0.5× 64 0.4× 93 0.9× 111 1.3× 111 1.0k
Sohee Han South Korea 14 314 0.8× 181 0.8× 64 0.4× 142 1.4× 38 0.4× 35 727
Danuta Owczarek Poland 16 185 0.5× 326 1.5× 187 1.2× 30 0.3× 162 1.9× 50 876
Maria Kulecka Poland 18 464 1.2× 76 0.3× 95 0.6× 146 1.4× 73 0.8× 67 871

Countries citing papers authored by Şükrü Palanduz

Since Specialization
Citations

This map shows the geographic impact of Şükrü Palanduz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükrü Palanduz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükrü Palanduz more than expected).

Fields of papers citing papers by Şükrü Palanduz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şükrü Palanduz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükrü Palanduz. The network helps show where Şükrü Palanduz may publish in the future.

Co-authorship network of co-authors of Şükrü Palanduz

This figure shows the co-authorship network connecting the top 25 collaborators of Şükrü Palanduz. A scholar is included among the top collaborators of Şükrü Palanduz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükrü Palanduz. Şükrü Palanduz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öztürk, Şükrü, et al.. (2025). MiR-7-5p May Inhibit AML Cell Proliferation Via SKP2, KLF4, OGT Target Genes. Clinical and Experimental Health Sciences. 15(1). 8–14. 1 indexed citations
2.
Karataş, Ömer Faruk, et al.. (2024). CDR1as/miR-7-5p/ IGF1R axis contributes to the suppression of cell viability in prostate cancer. SHILAP Revista de lepidopterología. 50(1). 89–98.
3.
Palanduz, Şükrü, et al.. (2024). Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets. SHILAP Revista de lepidopterología. 20(2). 102–109. 5 indexed citations
4.
Çefle, Kıvanç, et al.. (2024). Curcumin suppresses cell viability in breast cancer cell line by affecting the expression of miR-15a-5p. SHILAP Revista de lepidopterología. 49(5). 656–665. 4 indexed citations
5.
Palanduz, Şükrü, et al.. (2024). Overexpression of CDC25A, AURKB, and TOP2A Genes Could Be an Important Clue for Luminal A Breast Cancer. SHILAP Revista de lepidopterología. 20(4). 284–291. 2 indexed citations
6.
Palanduz, Şükrü, et al.. (2024). EFFECT of CURCUMIN on BREAST CANCER CELLS THROUGH miR-145-5p AND ITS TARGET GENES. SHILAP Revista de lepidopterología. 87(3). 235–245.
7.
Özgür, Emre, Ömer Faruk Karataş, Şükrü Öztürk, et al.. (2023). miR-145-5p suppresses cell proliferation by targeting IGF1R and NRAS genes in multiple myeloma cells. SHILAP Revista de lepidopterología. 48(5). 563–569. 7 indexed citations
8.
Yavuz, Akif Selim, et al.. (2022). OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment. Indian Journal of Hematology and Blood Transfusion. 38(4). 668–674.
9.
Erdem, Simge, Veysel Sabri Hançer, Meliha Nalçacı, et al.. (2021). A case mimicking chronic myeloid leukemia with t(8;22)(p11;q11)/BCR-FGFR1 and sequential transformation to B-acute lymphoblastic leukemia and acute myeloid leukemia. Journal of Hematopathology. 14(2). 151–156.
10.
11.
Öztürk, Şükrü, et al.. (2013). Genotoxicity of fixation devices analyzed by the frequencies of sister chromatid exchange. Ulusal travma dergisi. 19(4). 299–304. 1 indexed citations
12.
Aktan, Melih, Şükrü Öztürk, Şükrü Palanduz, et al.. (2011). Investigation of Arg399Gln and Arg194Trp Polymorphisms of the XRCC1 (X-Ray Cross-Complementing Group 1) Gene and Its Correlation to Sister Chromatid Exchange Frequency in Patients with Chronic Lymphocytic Leukemia. Genetic Testing and Molecular Biomarkers. 16(4). 287–291. 15 indexed citations
13.
Palanduz, Şükrü, Burçak Vural, Kıvanç Çefle, et al.. (2009). Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia. Genetic Testing and Molecular Biomarkers. 13(5). 599–602. 1 indexed citations
14.
Çefle, Kıvanç, Hasan Kudat, Hüseyin Oflaz, et al.. (2009). Left Ventricular Thickness Is Increased in Nonhypertensive Turner's Syndrome. Echocardiography. 26(8). 943–949. 17 indexed citations
15.
Öztürk, Şükrü, Kıvanç Çefle, Şükrü Palanduz, et al.. (2008). Effect of Cyclosporin A and Tacrolimus on Sister Chromatid Exchange Frequency in Renal Transplant Patients. Genetic Testing. 12(3). 427–430. 14 indexed citations
16.
Türkmen, Cüneyt, Şükrü Öztürk, Seher Ünal, et al.. (2007). The Genotoxic Effects in Lymphocyte Cultures of Children Treated with Radiosynovectomy by Using Yttrium-90 Citrate Colloid. Cancer Biotherapy and Radiopharmaceuticals. 22(3). 393–399. 19 indexed citations
17.
Palanduz, Şükrü, et al.. (2001). OXIDANT AND ANTIOXIDANT SYSTEMS IN NIDDM PATIENTS: INFLUENCE OF VITAMIN E SUPPLEMENTATION. Endocrine Research. 27(3). 377–386. 46 indexed citations
18.
Ademoğlu, Evin, Cahide Gökkuşu, & Şükrü Palanduz. (2000). Vitamin E and ATPases: Protection of ATPase Activities by Vitamin E Supplementation in Various Tissues of Hypercholesterolemic Rats. International Journal for Vitamin and Nutrition Research. 70(1). 3–7. 8 indexed citations
19.
Palanduz, Şükrü, et al.. (1999). Genotoxic potential of cyclosporin A in patients with renal transplantation. Cell Biology and Toxicology. 15(1). 13–17. 10 indexed citations
20.
Palanduz, Şükrü, et al.. (1998). 47,XYY Karyotype in Acute Myeloid Leukemia. Cancer Genetics and Cytogenetics. 106(1). 76–77. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Doneda Breakdown of academic impact, for papers by Jingfang Liu Breakdown of academic impact, for papers by Mercedes García-Bermúdez Breakdown of academic impact, for papers by Noriaki Iino Breakdown of academic impact, for papers by Jau-Yi Li Breakdown of academic impact, for papers by Naoko Yokota Breakdown of academic impact, for papers by Pratibha Nallari Breakdown of academic impact, for papers by Sohee Han Breakdown of academic impact, for papers by Danuta Owczarek Breakdown of academic impact, for papers by Maria Kulecka
Rankless by CCL
2026